Ashton Thomas Private Wealth, LLC
- SEC CIK
- 0002019663
- Latest filing
- Jul 29, 2026
LGND holding history
Ligand Pharmaceuticals Inc in every 13F filed by Ashton Thomas Private Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LGND overviewAll 13F holders of LGNDFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,704
- Value
- $538.6K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,704 | $538.6K | <0.1% | −490−22.3% | Reduced | Holders |
| Q1 2026 | 2,194 | $438.0K | <0.1% | +91+4.3% | Added | Holders |
| Q4 2025 | 2,103 | $397.6K | <0.1% | +89+4.4% | Added | Holders |
| Q3 2025 | 2,014 | $356.8K | <0.1% | +56+2.9% | Added | Holders |
| Q2 2025 | 1,958 | $222.6K | <0.1% | −25−1.3% | Reduced | Holders |
| Q1 2025 | 1,983 | $208.5K | <0.1% | +36+1.8% | Added | Holders |
| Q4 2024 | 1,947 | $208.6K | <0.1% | +1,947 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −1,891−100.0% | Sold out | Holders |
| Q2 2024 | 1,891 | $159.3K | <0.1% | +1,891 | New | Holders |